Predictive Oncology (NASDAQ:AGPU) Posts Earnings Results

Predictive Oncology (NASDAQ:AGPU) announced its quarterly earnings results on Friday. The company reported ($0.36) earnings per share for the quarter, FiscalAI reports. The business had revenue of $0.04 million during the quarter.

Predictive Oncology Stock Up 4.5%

Predictive Oncology stock opened at $5.85 on Friday. The business has a 50-day simple moving average of $3.86. The company has a market capitalization of $32.41 million, a price-to-earnings ratio of -0.46 and a beta of 3.45. Predictive Oncology has a 52 week low of $1.03 and a 52 week high of $32.10.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on AGPU shares. Wall Street Zen lowered Predictive Oncology to a “strong sell” rating in a research note on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Predictive Oncology in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Predictive Oncology Company Profile

Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.

Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.